Ofir Koren Net Worth

The estimated Net Worth of Ofir Koren is at least $7.58 Thousand dollars as of 7 June 2019. Mr. Koren owns over 358 units of Rewalk Robotics Ltd stock worth over $5,245 and over the last 8 years he sold RWLK stock worth over $2,331. In addition, he makes $0 as Vice President - Research & Development at Rewalk Robotics Ltd.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Koren RWLK stock SEC Form 4 insiders trading

Ofir has made over 2 trades of the Rewalk Robotics Ltd stock since 2017, according to the Form 4 filled with the SEC. Most recently he sold 358 units of RWLK stock worth $2,331 on 7 June 2019.

The largest trade he's ever made was exercising 5,220 units of Rewalk Robotics Ltd stock on 3 January 2017 worth over $6,890. On average, Ofir trades about 620 units every 98 days since 2016. As of 7 June 2019 he still owns at least 4,995 units of Rewalk Robotics Ltd stock.

You can see the complete history of Mr. Koren stock trades at the bottom of the page.

Ofir Koren biography

Ofir Koren serves as Vice President - Research & Development of ReWalk Robotics Ltd., since February 2013. From 2009 to 2013, Mr. Koren served as General Manager of RuggedCOM Israel, a developer of communications equipment. From 2007 to 2009, he served as the Vice President of Research and Development of Alvarion Technologies Ltd., an Israeli provider of wireless services. Mr. Koren holds a B.Sc. in electrical engineering from Tel Aviv University and an MBA from the University of Herriot Watt, Scotland.

How old is Ofir Koren?

Ofir Koren is 47, he's been the Vice President - Research & Development of Rewalk Robotics Ltd since 2013. There are 11 older and 3 younger executives at Rewalk Robotics Ltd. The oldest executive at Rewalk Robotics Ltd is Ami Kraft, 78, who is the Exec. Advisor to the CEO.

What's Ofir Koren's mailing address?

Ofir's mailing address filed with the SEC is HaTnufa St, Yokne'am Illit, Israel.

Insiders trading at Rewalk Robotics Ltd

Over the last 9 years, insiders at Rewalk Robotics Ltd have traded over $7,660,045 worth of Rewalk Robotics Ltd stock and bought 8,170,475 units worth $6,701,652 . The most active insiders traders include Global Fund Ii Lp Lind Glob..., Glenn P Muir, and Wayne Weisman. On average, Rewalk Robotics Ltd executives and independent directors trade stock every 26 days with the average trade being worth of $88,081. The most recent stock trade was executed by Global Fund Ii Lp Lind on 17 November 2023, trading 54,917 units of RWLK stock currently worth $40,089.

What does Rewalk Robotics Ltd do?

exoskeleton leader rewalk robotics, inc. (formerly argo medical technologies) develops, manufactures and markets wearable robotic exoskeletons for individuals with spinal cord injury (sci). rewalk’s mission is to fundamentally change the health and life experiences of individuals with spinal cord injury. founded in 2001, rewalk has headquarters in the us, israel and germany. rewalk robotics' rewalk is a wearable robotic exoskeleton that provides powered hip and knee motion to enable individuals with spinal cord injury (sci) to stand upright and walk. rewalk is the only exoskeleton with fda clearance via clinical studies and extensive performance testing for personal use rewalk has been tested extensively in the u.s., europe, and israel. the rewalk system is supported by the most published data of all exoskeleton systems in the rehabilitation market, and is used by more people worldwide than all other exoskeleton systems combined. the company offers two products: rewalk personal and the

Complete history of Mr. Koren stock trades at Rewalk Robotics Ltd

Rewalk Robotics Ltd executives and stock owners

Rewalk Robotics Ltd executives and other stock owners filed with the SEC include:

• Lawrence Jasinski,
  Chief Executive Officer, Director
• Lawrence J. Jasinski,
  CEO & Director
• Ori Gon,
  CFO & Principal Accounting Officer
• Wayne Weisman,
  Independent Director
• John Poduska,
  Independent Director
• Randel Richner,
  Director
• Yasushi Ichiki,
  Director
• Yohanan Engelhardt,
  Director
• Aryeh Dan,
  Director
• Jeff Dykan,
  Independent Chairman of the Board
• Jodi Gricci,
  Vice President - Global Marketing and Training
• Ofir Koren,
  Vice President - Research & Development
• Ori Gon,
  Chief Financial Officer
• Kathleen O'Donnell,
  VP of Marketing & New Bus. Devel.
• Ami Kraft,
  Exec. Advisor to the CEO
• Judy Kula,
  VP of Customer Service, HR & Bus. Affairs
• Andy Dolan,
  VP of Marketing & Reimbursement
• Miri Pariente,
  VP of Operations, Regulatory & Quality
• Peter Wehrly,
  Director
• Kevin Hershberger,
  Chief Financial Officer
• Vitalife Partners (Israel) ...,
  
• Vitalife Partners Ii Lpscp ...,
  
• Vitalife Partners Ii Lpscp ...,
  
• Glenn P Muir,
  Director
• Deborah Di Sanzo Eldracher,
  Director
• Vitalife Partners (Israel) ...,
  
• John Vincent Hamilton,
  VP, Regulatory & Clinical
• Chunlin Han,
  Director
• Vitalife Partners Ii Lpscp ...,
  
• Vitalife Partners (Israel) ...,
  
• Ning Cong,
  
• Global Fund Ii Lp Lind Glob...,
  
• Joseph E Jr Turk,
  Director
• Jeannine Lynch,
  VP of Market Access & Strategy
• Hadar Levy,
  Director
• Almog Adar,
  VP of Finance
• Michael A Lawless,
  Chief Financial Officer
• Global Fund Ii Lp Lind,
  
• Charles Remsberg,
  Chief Sales Officer